Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MACITENTAN for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 29,246 adverse event reports in the FDA FAERS database where MACITENTAN was used for Pulmonary arterial hypertension.

Most Reported Side Effects for MACITENTAN

Side Effect Reports % Deaths Hosp.
Dyspnoea 8,315 18.4% 1,685 5,903
Death 5,864 12.9% 5,789 2,120
Headache 4,856 10.7% 575 2,694
Diarrhoea 3,669 8.1% 574 2,268
Pneumonia 3,531 7.8% 810 3,162
Nausea 3,463 7.6% 456 2,116
Hospitalisation 3,414 7.5% 500 3,372
Fatigue 3,172 7.0% 485 1,899
Fluid retention 2,861 6.3% 575 2,150
Dizziness 2,704 6.0% 337 1,673
Malaise 2,521 5.6% 431 1,590
Pulmonary arterial hypertension 2,390 5.3% 1,204 1,695
Hypotension 2,318 5.1% 519 1,691
Cough 2,294 5.1% 314 1,404
Condition aggravated 2,198 4.9% 638 1,538

Other Indications for MACITENTAN

Product used for unknown indication (9,498) Pulmonary hypertension (5,228) Cor pulmonale chronic (254) Portopulmonary hypertension (153) Connective tissue disorder (107) Systemic scleroderma (74) Pulmonary embolism (68) Heart disease congenital (56) Heritable pulmonary arterial hypertension (43) Right-to-left cardiac shunt (32)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828) BOSENTAN\BOSENTAN (2,673)

Related Pages

MACITENTAN Full Profile All Pulmonary arterial hypertension Drugs MACITENTAN Demographics MACITENTAN Timeline